A 43-year-old transgender woman is prescribed daily tenofovir DF-emtricitabine for HIV preexposure prophylaxis (PrEP) at an initial visit. Her baseline estimated creatinine clearance is 98 mL/min.
Which one of the following should be recommended as follow-up laboratory monitoring for renal function in this individual taking daily tenofovir DF-emtricitabine for HIV PrEP?
Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Since you are not signed in, your progress won't be saved.
Question Last Updated
September 20th, 2023
September 20th, 2023
Steps to Acquire CE for this Question Bank Topic:
1
Answer
Answer all questions
2
Score 80%+
Answer correctly
3
Claim CE
Choose CNE or CME
4
Give Feedback
Complete survey
5